ReviewInternational ophthalmology2025
Ferroptosis in Müller cells under hyperglycemia: mechanisms and therapeutic implications for diabetic retinopathy-associated optic neuroinflammation.
Review in International ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- The Eye as a Window to Neurodegeneration: Oxidative Stress, Optic Nerve Vulnerability, and Retinal Biomarkers-A Scoping Review.Antioxidants (Basel, Switzerland) · 2026Review
- Ferroptosis-inflammasome crosstalk contributes to hyperglycemia-induced neuronal injury and is modulated by the ferroptosis inhibitor UAMC-3203.Molecular biology reports · 2026Article
- Ferroptosis in diabetic retinopathy: cellular heterogeneity, progression, and therapeutic targets.Molecular biology reports · 2026Review
- Ranitidine protects Müller cells against ferroptosis in diabetic retinopathy by regulating the AKT1/GSK3β pathway.Indian journal of ophthalmology · 2026Article
- Ferroptosis in diabetic retinopathy: from pathogenic mechanisms to translational prospects.Frontiers in endocrinology · 2026Review
- Metabolic reprogramming in diabetic complications: mechanisms, pathologies, and molecular evidence from multi-organ studies.Frontiers in immunology · 2026Review
- Regulatory role of the circHIPK3/miR-125a-5p/NDUFA5 axis in diabetic retinopathy: combined analysis of single-cell and bulk transcriptomes.American journal of translational research · 2026Article
- Vacuolar protein sorting 35 regulates retinal neurovascular functionInternational journal of ophthalmology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundDiabetic retinopathy (DR), traditionally considered a microvascular complication, is now increasingly recognized as a neurodegenerative and neuroinflammatory disorder. Among retinal glial cells, Müller cells are particularly susceptible to hyperglycemia-induced stress, playing a pivotal role in the progression of DR.
objectiveThis review aims to systematically summarize the mechanisms by which high glucose induces ferroptosis in Müller cells and to explore the implications of ferroptotic damage for retinal neuroinflammation and blood-retinal barrier dysfunction in DR.
methodsA comprehensive literature review was conducted focusing on recent experimental and translational studies related to ferroptosis pathways in diabetic retinal environments, particularly involving Müller cell pathology.
resultsHyperglycemia promotes Müller cell ferroptosis via three major axes: 1. Iron metabolism dysregulation, including TfR1/DMT1 upregulation and autophagic degradation of ferritin (ferritinophagy); 2. Enhanced lipid peroxidation, driven by ACSL4 and lipoxygenase (LOX) activity; 3. Antioxidant system impairment, notably via suppression of the system Xc⁻/GPX4 axis. Ferroptosis in Müller cells contributes to neuroinflammation through the release of damage-associated molecular patterns (DAMPs), activation of retinal microglia, and disruption of the blood-retinal barrier.
conclusionFerroptosis is a critical and previously underappreciated mechanism linking metabolic stress to neuroinflammation in DR. Targeting ferroptosis-via iron chelation, GPX4 restoration, or activation of the Nrf2 pathway-represents a promising therapeutic strategy to mitigate retinal neurodegeneration in diabetic patients.
Indexed as
Identifiers
40690064What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.